Suzetrigine: A Selective Inhibitor of the NaV1.8 Sodium Channel. (PubMed, Cureus) - Sep 30, 2026 - "Current evidence gaps include limited data across comprehensive surgical populations, multimodal comparative effectiveness of trials, and undefined safety outcomes. Perioperative analgesic regimens can be optimized by prioritizing research addressing areas with insufficient evidence."
Journal • Review • Pain • NAV1
|
|
Daniel Bach; George Wilkins; Kevin Tran; Paramveer Brar; Sudhakar Pemminati; Zachary Yamada
|